<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药智网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-17T12:21:29+08:00</updated>
  <subtitle>一个有态度、有深度、有温度的医药健康领域融媒体平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>【药咖君】复星凯特CAR-T上市在即！PD-1单抗适应症之争还在继续，百济神州、信达…</title>
    <updated>2021-01-17T10:06:13+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/O0UhLJV3bnMrj4ScpZJXBQ</id>
    <link href="https://mp.weixin.qq.com/s/O0UhLJV3bnMrj4ScpZJXBQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>高层定调“药品集采常态化制度化”！2021将是十年以来真正的招标大年！</title>
    <updated>2021-01-15T23:40:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/tWh1kmToK4Jjhe0sILtnXg</id>
    <link href="https://mp.weixin.qq.com/s/tWh1kmToK4Jjhe0sILtnXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从0到180亿，谢良志和他的“重组蛋白药物王国”</title>
    <updated>2021-01-15T23:40:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/3oQjWyKM7GwthgFxEeAtuQ</id>
    <link href="https://mp.weixin.qq.com/s/3oQjWyKM7GwthgFxEeAtuQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品主战场仍是“小分子”，“Protac”或是赶超海外药企的关键</title>
    <updated>2021-01-15T16:40:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/zylf0f86B5B8HNxY810a1Q</id>
    <link href="https://mp.weixin.qq.com/s/zylf0f86B5B8HNxY810a1Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【好药记】一致性评价新进展：多品种冲线，10亿级抗肿瘤药不断；罗欣、石家庄四药、康恩贝...</title>
    <updated>2021-01-15T16:40:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/cfdTMkgE4rY7GCTEHQxE7w</id>
    <link href="https://mp.weixin.qq.com/s/cfdTMkgE4rY7GCTEHQxE7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>涉严重不良反应，2款药品全面召回、停销、停用！</title>
    <updated>2021-01-15T16:40:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/EHy42SAdAy8C0oboS1b43A</id>
    <link href="https://mp.weixin.qq.com/s/EHy42SAdAy8C0oboS1b43A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年，药店面临3大挑战</title>
    <updated>2021-01-15T16:40:39+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/H2XkcBS6p_w6ckvuZ-PZoQ</id>
    <link href="https://mp.weixin.qq.com/s/H2XkcBS6p_w6ckvuZ-PZoQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>李天泉：通过数据透视成渝医药发展趋势与机遇</title>
    <updated>2021-01-14T16:56:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/3DrBfTUDi8MfdphMPsOwpg</id>
    <link href="https://mp.weixin.qq.com/s/3DrBfTUDi8MfdphMPsOwpg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>康弘药业：34.7亿定增助推国际化蓝图</title>
    <updated>2021-01-14T16:56:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/01GChOrukGxJYSXGMqE05A</id>
    <link href="https://mp.weixin.qq.com/s/01GChOrukGxJYSXGMqE05A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗有效率不及预期？巴西公布科兴疫苗有效率为50.4%</title>
    <updated>2021-01-14T16:56:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/0HBykKpmKyOz7lFZLWkEGA</id>
    <link href="https://mp.weixin.qq.com/s/0HBykKpmKyOz7lFZLWkEGA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采最新格局出炉，春节前能报价落地？</title>
    <updated>2021-01-14T16:56:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-14:/s/D0fmS37EIUDTAk9rLwierA</id>
    <link href="https://mp.weixin.qq.com/s/D0fmS37EIUDTAk9rLwierA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点：美国FDA和EMA批准新药销售峰值预测！吉利德、Vertex最大赢家，罗氏、辉瑞、诺华....</title>
    <updated>2021-01-13T16:22:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/dTyj9YCHCBLqWnrcNYx2QA</id>
    <link href="https://mp.weixin.qq.com/s/dTyj9YCHCBLqWnrcNYx2QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品上市持有人注意！《药品上市后变更管理办法（试行）》来了</title>
    <updated>2021-01-13T16:22:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/OD6GzeArRZhOo71D8KABqQ</id>
    <link href="https://mp.weixin.qq.com/s/OD6GzeArRZhOo71D8KABqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新办证不足一年 天津车元医疗被要求停产整改</title>
    <updated>2021-01-13T16:22:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/NQ9r5bNpLESegrHjumkaPg</id>
    <link href="https://mp.weixin.qq.com/s/NQ9r5bNpLESegrHjumkaPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020年度美国市场注射剂召回情况盘点，FDA共召回药品110例</title>
    <updated>2021-01-13T16:22:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-13:/s/zJToasgu-e1ASjoF13jGJA</id>
    <link href="https://mp.weixin.qq.com/s/zJToasgu-e1ASjoF13jGJA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>200亿血友病蓝海，国产重组凝血因子VIII即将实现“0”的突破</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/xzZiNAJxuyCiFd_hj3k-LQ</id>
    <link href="https://mp.weixin.qq.com/s/xzZiNAJxuyCiFd_hj3k-LQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年第一集采来了！8省区，17品种纳入（附名单）</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/doMjgZrT_pDiVyBWbhSE6g</id>
    <link href="https://mp.weixin.qq.com/s/doMjgZrT_pDiVyBWbhSE6g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>刘昌孝：双循环战略促进后新冠疫情时期的生物医药创新发展</title>
    <updated>2021-01-12T17:26:05+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-12:/s/jbeOctGVotZhBMU6jgLRRA</id>
    <link href="https://mp.weixin.qq.com/s/jbeOctGVotZhBMU6jgLRRA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020盘点:「化药1类」进口IND品种分析，罗氏、诺华、百济、信达…</title>
    <updated>2021-01-11T16:52:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/aNxl-GsCqkTBMaB_Ofxtyw</id>
    <link href="https://mp.weixin.qq.com/s/aNxl-GsCqkTBMaB_Ofxtyw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企老司机安进(Amgen)，研发管线布局有何特别之处？</title>
    <updated>2021-01-11T16:52:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-11:/s/yGvKDyPlJGwp7HwcrEJPHw</id>
    <link href="https://mp.weixin.qq.com/s/yGvKDyPlJGwp7HwcrEJPHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>